What we are doing:

PTC concerns with advanced pre-formulation and formulation studies, sophisticated scale-up and Process design, development of manufacturing technology, and advanced analytical method development for new and generic small as well as macro-molecules anti-cancer drugs in solid and parenteral dosage forms.
PTC designs and prepares all pharmaceutical industrial studies that are required for pharmaceutical companies that are interested in manufacturing and developing anti-cancer medicines for commercial use.
PTC can help cancer research centres and pharmacy academic colleges in the universities for covering all their needs of formulated samples of new anti-cancer drugs for pre-clinical, clinical, and toxicity studies

PTC's laboratories have three main departments:

Anti-cancer Drug Formulation Department

Pharmaceutical anti-cancer Formulation development is a key area of anti cancer development that can determine patentability, lifecycle, and, ultimately, the success of a pharmaceutical anti-cancer product. The anti cancer drug formulation issues, including stability, solubility, and bioavailability, have been identified as key concerns in anti-cancer drug development. The challenges in a pharmaceutical formulation often arise from the different physicochemical attributes of a molecule and the need to deliver the compound to the desired site.   Based on the profound knowledge of properties of client’s anti-cancer drug candidates and inactive components, our scientists will guide our client through decisions and provide advice to design the most appropriate formulations regarding the release characteristics or bioavailability.
We are specialized in designing and development of various dosage forms of anti-cancer drugs, including tablets, capsules, and sterile liquids and suspensions as well as sustained or extend formulations. PTC formulation department is equipped with high-talent pre-formulation and formulation equipment that enable performing and troubleshooting of all anti-cancer drug formulations with high-experienced stuff.

Anti-cancer Drug Analysis Department

PTC-lab anti-cancer drug analysis Department involves a series of processes for the identification, determination, quantification, and purification of a substance, separation of the components of a solution or mixture, or determination of the structure of anti-cancer compounds.
The laboratory in this department is equipped with advanced facilities, keeping in view the need for anti-cancer drug analysis accuracy and precision. PTC’s analytical laboratory includes a wide range of instrumentation whose main purpose is to qualitatively and quantitatively analyse anti-cancer drug samples. The broad range of available equipment also allows for a wide range of testing procedures and their respective applications. PTC’s analytical lab provided their cross-discipline compatibility to analyse samples. 

PTC's Analysis Areas:

Anti-cancer drugs Stability Study Department

A stability study is a vital stake in the anti-cancer drug development process. Stability is the only way that assures whether the anti-cancer drug is within acceptance criteria or not. Stability comes into focus when the quality and efficiency of the anti-cancer drug are concerned.

PTC ‘s stability study department provides the necessary data for the shipping and distribution of anti-cancer drug products. In this department, three ensured stabilities are studied which are physical, chemical, and microbiological.
In PTC, a stability study is performed at various stages of the anti-cancer drug development process. At the early stage of drug development, accelerated stability studies are performed to find out the rate of degradation of the product if stored for a longer period under specific conditions. After that, a forced degradation study is carried out to check the effect of stressed external conditions on the drug product.

In our PTC's stability department, we are mainly concerned with the following types of stability studies: